Equities
Health CareMedical Equipment and Services
  • Price (USD)258.16
  • Today's Change5.15 / 2.03%
  • Shares traded151.15k
  • 1 Year change-18.82%
  • Beta1.6343
Data delayed at least 15 minutes, as of Sep 19 2024 16:09 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Consensus recommendation

  • 14-Sep-23
  • 20-Jun-24
  • 18-Jul-24
  • 15-Aug-24
  • 12-Sep-24
Select bar for recommendation details.
Recommendations12-Sep-24
Buy4
Outperform4
Hold6
Sell1
Strong Sell0

Share price forecast in USD

The 12 analysts offering 12 month price targets for Align Technology, Inc. have a median target of 285.00, with a high estimate of 350.00 and a low estimate of 215.00. The median estimate represents a 12.64% increase from the last price of 253.01.
High38.3%350.00
Med12.6%285.00
Low-15.0%215.00

Earnings history & estimates in USD

On Jul 24, 2024, Align Technology, Inc. reported 2nd quarter 2024 earnings of 2.41 per share. This result was in line with the consensus of the 10 analysts following the company and exceeded last year's 2nd quarter results by 8.56%.
The next earnings announcement is expected on Oct 23, 2024.
Average growth rate+2.63%
Align Technology, Inc. reported annual 2023 earnings of 8.61 per share on Jan 31, 2024.
Average growth rate+22.19%
More ▼

Revenue history & estimates in USD

Align Technology, Inc. had 2nd quarter 2024 revenues of 1.03bn. This missed the 1.04bn consensus estimate of the 10 analysts following the company. This was 9.05% above the prior year's 2nd quarter results.
Average growth rate+0.70%
Align Technology, Inc. had revenues for the full year 2023 of 3.86bn. This was 3.42% above the prior year's results.
Average growth rate+15.13%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.